Hjem › Parkinsons sygdom › Kansas
Parkinsons sygdom kliniske forsøg i Kansas
10 studier for Parkinsons sygdom søger deltagere på steder i Kansas.
Byer i Kansas
Officiel studietekst (engelsk)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- University of Kansas Medical Center, Kansas City
RekruttererFase 2
Alder 40 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06680830A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-029, Kansas City
RekruttererFase 2/3
Alder 40 til 80 · Alle køn · Opdateret 28. sep. 2026 · NCT06976268A Study of Buntanetap in Participants With PD
- University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D, Kansas City
RekruttererFase 2/3
Alder 40 til 85 · Alle køn · Opdateret 21. sep. 2026 · NCT07284784A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #041, Overland Park
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 11. sep. 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- The University of Kansas (KU) (Site #216), Kansas City
RekruttererFase 2
Alder 30 til 80 · Alle køn · Opdateret 10. sep. 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- University of Kansas, Lawrence
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT04994015A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- University of Kansas Medical Center, Kansas City
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 3. sep. 2026 · NCT07174310A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- University of Kansas Medical Center, Kansas City
RekruttererFase 3
Alder 45 til 75 · Alle køn · Opdateret 4. aug. 2026 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- University of Kansas Medical Center, Kansas City
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 30 og opefter · Alle køn · Opdateret 27. jul. 2026 · NCT04477785A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- University of Kansas Medical Center, Kansas City
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2025 · NCT06765668Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.